Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.
about
Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbitsStatins: definitive translational researchPotential use of γ-secretase modulators in the treatment of Alzheimer diseaseA century of cholesterol and coronaries: from plaques to genes to statinsThematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversyPeripheral neuropathy associated with simvastatin.Statin Use and Risk of Cirrhosis and Related Complications in Patients with Chronic Liver Diseases: a Systematic Review and Meta-analysis.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsA historical perspective on the discovery of statins.5 alpha-Cholest-8(14)-en-3 beta-ol-15-one, a potent inhibitor of sterol biosynthesis, lowers serum cholesterol and alters distributions of cholesterol in lipoproteins in baboons.Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study.Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductaseHypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Brain and optic system pathology in hypocholesterolemic dogs treated with a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.Statins: past and present.Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers.Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activityWindow panes of eternity. Health, disease, and inherited riskA gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.Update on statin-mediated anti-inflammatory activities in atherosclerosis.The influence of mevinolin on the adrenal cortical response to corticotropin in heterozygous familial hypercholesterolemia.Hydroxymethylglutaryl-coenzyme A reductase-containing hepatocytes are distributed periportally in normal and mevinolin-treated rat livers.Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan.CHOLESTEROL AND NEURONAL SUSCEPTIBILITY TO BETA-AMYLOID TOXICITY.Pathophysiology of human lipoprotein receptors: clinical consequences of a cellular defect.Regulation of low density lipoprotein receptor function in a human hepatoma cell line.Lowering plasma cholesterol by raising LDL receptors--revisited.Activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase does not respond to ubiquinone uptake in cultured cellsAntioxidant activity of ubiquinone-3 in human low density lipoprotein.A gift from nature: the birth of the statins.Genome-wide and Phenome-wide Approaches to Understand Variable Drug Actions in Electronic Health Records.Hyperlipidemia. What is 'normal,' who should be treated and how.Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017A new grammar for drug discovery
P2860
Q24628996-A038D0C5-7A6F-4726-A9E6-0E567C504847Q26851528-7E747F79-A729-4A5F-A43D-C27DFE13E090Q27004876-9A514699-50A6-4EDA-9DD7-3DFCF9807C1BQ28080618-036459A2-009E-4E0D-8E1B-BA12D2E04FF9Q28305315-B87CC36D-6FBF-4099-BF6D-58A23C7C647BQ28368111-944299A1-0752-4DFD-AA30-5238D9C10E56Q30234533-E33C20FF-AD0D-4E6C-8736-B0680225A91AQ30814231-F32641CD-13BF-4E35-A985-79D6E1454E33Q34022421-E55129A8-611B-4FCE-8A04-6EB8AAE30AF8Q34273886-CF43ECE2-52A0-4957-B910-1D47329CE3D6Q34362558-8878E334-CABA-44C8-A227-7AC1C398B526Q34563781-121DDA2D-F18F-4A0C-B08A-733A064D4792Q34621428-80FBD348-9493-402F-B3A2-186CA270C3A3Q35819003-3F747CC3-8A21-44D8-92D2-2F6DA05A89B9Q35936339-761984FA-B00A-4CB8-B34F-1CE535792ADFQ36258094-1E4F350B-C7A0-4933-BEBE-26CD4BE346FBQ36982518-0DE8797A-26C3-41DC-BAB3-C9B23ABE2096Q36992215-79C01640-9965-4BFC-B3C4-CE13E2A6770EQ37000495-D3B22694-395B-4A87-9634-25C962D442D4Q37316153-BA6B25D0-F33B-4547-99D4-FA20B9E5CFE8Q37470209-E44356FE-6A3E-48B9-8445-5D21CE9C9644Q37542969-AA6E8245-AF9C-4E27-AB9C-5055AEC8143EQ37566775-AB67DDD9-614D-4853-A33D-60A16D19CA55Q37616687-5002F711-29AD-4068-A766-AADDDB1C54CCQ37740339-35CA8ABD-32D0-42AC-A449-FC5EC9C424A7Q38262127-9198ADE0-5033-43CC-8453-6E971AE9E371Q39522583-8E5FF645-FCB7-4CB4-B301-2605AF6E57C1Q41918714-C1B3F0DA-5F7A-49A0-82F3-ACB77FE40F03Q42363352-BF724A8F-FED1-4166-900B-9D7150BAA790Q42856713-74B01724-8899-42B6-BB23-CC743F388EB7Q43676646-8F2D3E54-9F0F-4A0E-8CB6-0BB5DB19CA4BQ46326946-C649E8E3-91E0-432D-81D0-4C16FF00A5BDQ49931634-1F953498-323F-4043-B040-621C8A8F3E82Q51659079-699340E1-BCAF-428D-9309-FEF9E7C7D200Q58362346-9430BFD2-7836-42D4-BAB9-CAD0FCD69D9AQ59052529-44A80D86-7B7D-45F7-8956-F77D46E09F63
P2860
Effect of an inhibitor of 3-hydroxy-3-methyglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10-levels in patients with familial hypercholesterolemia.
description
1981 nî lūn-bûn
@nan
1981 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@ast
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@en
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@nl
type
label
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@ast
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@en
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@nl
prefLabel
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@ast
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@en
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@nl
P2093
P1476
Effect of an inhibitor of 3-hy ...... familial hypercholesterolemia.
@en
P2093
A Watanabe
S Miyamoto
T Wakasugi
P304
P356
10.1056/NEJM198108273050902
P407
P577
1981-08-01T00:00:00Z